163 related articles for article (PubMed ID: 10037511)
1. p53 immunohistochemical expression in early posttransplant-associated malignant and premalignant cutaneous lesions.
Ferrándiz C; Fuente MJ; Fernández-Figueras MT; Bielsa I; Just M
Dermatol Surg; 1999 Feb; 25(2):97-101. PubMed ID: 10037511
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients.
Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
Br J Cancer; 1994 Oct; 70(4):662-7. PubMed ID: 7917913
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
4. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses.
McGregor JM; Farthing A; Crook T; Yu CC; Dublin EA; Levison DA; MacDonald DM
J Am Acad Dermatol; 1994 May; 30(5 Pt 1):701-6. PubMed ID: 8176007
[TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):924-31. PubMed ID: 9204056
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.
Onodera H; Nakamura S; Sugai T
Am J Dermatopathol; 1996 Dec; 18(6):580-8. PubMed ID: 8989929
[TBL] [Abstract][Full Text] [Related]
9. p53 protein expression in benign and malignant skin tumours.
Ro YS; Cooper PN; Lee JA; Quinn AG; Harrison D; Lane D; Horne CH; Rees JL; Angus B
Br J Dermatol; 1993 Mar; 128(3):237-41. PubMed ID: 8471506
[TBL] [Abstract][Full Text] [Related]
10. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p53 nuclear protein in premalignant and malignant laryngeal lesions.
Nakashima T; Wang XF; Masuda M; Inokuchi A; Komiyama S
Eur Arch Otorhinolaryngol; 1999; 256 Suppl 1():S56-9. PubMed ID: 10337529
[TBL] [Abstract][Full Text] [Related]
12. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.
Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
Br J Cancer; 1994 Feb; 69(2):222-9. PubMed ID: 8297718
[TBL] [Abstract][Full Text] [Related]
14. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours.
Khorshid SM; Glover MT; Churchill L; McGregor JM; Proby CM
J Cutan Pathol; 1996 Jun; 23(3):229-33. PubMed ID: 8793657
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers.
Nelson MA; Einspahr JG; Alberts DS; Balfour CA; Wymer JA; Welch KL; Salasche SJ; Bangert JL; Grogan TM; Bozzo PO
Cancer Lett; 1994 Sep; 85(1):23-9. PubMed ID: 7923098
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 expression in solar keratosis: an immunohistochemical study.
Sim CS; Slater S; McKee PH
J Cutan Pathol; 1992 Aug; 19(4):302-8. PubMed ID: 1430469
[TBL] [Abstract][Full Text] [Related]
17. Micronuclei and p53 accumulation in preneoplastic and malignant lesions of the head and neck.
Delfino V; Casartelli G; Garzoglio B; Scala M; Mereu P; Bonatti S; Margarino G; Abbondandolo A
Mutagenesis; 2002 Jan; 17(1):73-7. PubMed ID: 11752237
[TBL] [Abstract][Full Text] [Related]
18. Number of Langerhans cells is decreased in premalignant keratosis and skin cancers.
Shevchuk Z; Filip A; Shevchuk V; Kashuba E
Exp Oncol; 2014 Mar; 36(1):34-7. PubMed ID: 24691282
[TBL] [Abstract][Full Text] [Related]
19. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.
Benjamin CL; Melnikova VO; Ananthaswamy HN
Adv Exp Med Biol; 2008; 624():265-82. PubMed ID: 18348463
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA.
Pélisson I; Chardonnet Y; Euvrard S; Schmitt D
Virchows Arch; 1994; 424(6):623-30. PubMed ID: 8055156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
